Earth Life Sciences (Earth Life Sciences) Research & Development : $0.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 2003. Start your Free Trial

What is Earth Life Sciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Earth Life Sciences's Research & Development for the three months ended in Sep. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil.

Earth Life Sciences Research & Development Historical Data

The historical data trend for Earth Life Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Earth Life Sciences Research & Development Chart

Earth Life Sciences Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Research & Development

Get a 7-Day Free Trial

Earth Life Sciences Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22	Sep22
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Earth Life Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Earth Life Sciences (OTCPK:CLTS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Earth Life Sciences Research & Development Related Terms

Thank you for viewing the detailed overview of Earth Life Sciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Earth Life Sciences (Earth Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Earth Life Sciences Inc (OTCPK:CLTS) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

828 Harbourside Drive, Suite 209, North Vancouver, BC, CAN, V7P 3R9

Website

https://www.earthlifesciences.net

Earth Life Sciences Inc offers Artificial Intelligence (AI)-driven mileage-based loyalty system for public transportation. The Miltean's AI platform enables an increase of ridership, decongestion analysis, interruption of service compensation, congestion management, prediction and analysis of ridership usage patterns. The firm caters to public traffic management systems and team up relationships between private and public enterprise.

Executives

John Farinaccio	director, officer: Vice President	7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Jocelyn Moisan	director, officer: Predident	7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
George Tsolakos	officer: VP Business Development	7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Angelo M Marino	director, officer: Secretary and Vice President	7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Uwd Unitas World Development Inc.	10 percent owner	7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Greg A Thompson	director	11123 TUPPER LAKE DRIVE, HOUSTON TX 77042
Darrell Parlee	officer: Treasurer	2144 CROWBRIDGE DRIVE, FRISCO TX 75034
Andy Kim	director	1408 STONE CUTTER DR., OAKVILLE A1 00000
Steve Bajic	officer: Secretary	918-1030 WEST GEORGIA STREET, VANCOUVER A1 V6E 2Y3
Donald L Sytsma	director, officer: CFO and Treasurer	2404 ECHO HARBOR DRIVE, PEARLAND TX 77584
Bassam Nastat	director	5631 WINCH ST, BURNABY BC A1 V5B 2J4
Milton Cox	director, officer: President	7227 WINCHESTER RD #258, MEMPHIS TN 38118
Michael P Twyman	director, 10 percent owner, officer: President
Andrew B Stewart	director, 10 percent owner, officer: Secretary	1208 1030 W GEORGIA ST, VANCOUVER BC A1 9999999999